Back

How to manage ACS patients who require oral anticoagulation?

28 August 2017 (09:15 - 09:37)
Organised by:
Congress Presentation Part of: Starting, stopping, and everything in between: recent data concerning dual antiplatelet therapy in ACS Thrombosis and platelets ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Jurrien M ten Berg

St Antonius Hospital, Nieuwegein (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
When should we start P2Y12 inhibitors in patients with an acute coronary syndrome?
Professor G. Montalescot (Paris, FR)
Slides Video
Presentation thumbnail
Role of intravenous antiplatelet drugs in acute coronary syndromes
Professor D. Angiolillo (Jacksonville, US)
Slides Video
Presentation thumbnail
How long is long enough? When to stop DAPT after an acute coronary syndrome?
Doctor L. Mauri (Boston, US)
Slides Video

Access the full session

Session thumbnail
Starting, stopping, and everything in between: recent data concerning dual antiplatelet therapy in ACS

The Event

Event poster

ESC Congress 2017

28 August 2017 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Anticoagulation in patients with new-onset atrial fibrillation after acute coronary syndrome
29 June 2021
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Oral anti-coagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the (ORIGAMI) study
29 June 2021
thumbnail
Congress Presentation
Safety of dual antiplatelet pre-treatment in ACS patients undergoing unplanned aortocoronary bypass surgery
15 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources